Kabi F, Contreras M, Semakula J, Sanchez-Sanchez M, Munoz-Hernandez C, Mugerwa S
NPJ Vaccines. 2024; 9(1):174.
PMID: 39294184
PMC: 11410822.
DOI: 10.1038/s41541-024-00966-1.
de la Fuente J, Contreras M
Front Immunol. 2023; 14:1172734.
PMID: 37398646
PMC: 10307952.
DOI: 10.3389/fimmu.2023.1172734.
Dudley M, Gerber J, Budigan Ni H, Blunt M, Holroyd T, Carleton B
Vaccine. 2023; 41(14):2357-2367.
PMID: 36803903
PMC: 10065969.
DOI: 10.1016/j.vaccine.2023.02.009.
Traversi D, Pulliero A, Izzotti A, Franchitti E, Iacoviello L, Gianfagna F
J Pers Med. 2021; 11(2).
PMID: 33669364
PMC: 7920275.
DOI: 10.3390/jpm11020135.
Cotugno N, Santilli V, Pascucci G, Manno E, de Armas L, Pallikkuth S
Front Immunol. 2020; 11:559590.
PMID: 33123133
PMC: 7569088.
DOI: 10.3389/fimmu.2020.559590.
Current Challenges in Vaccinology.
Kennedy R, Ovsyannikova I, Palese P, Poland G
Front Immunol. 2020; 11:1181.
PMID: 32670279
PMC: 7329983.
DOI: 10.3389/fimmu.2020.01181.
Personalized vaccinology: A review.
Poland G, Ovsyannikova I, Kennedy R
Vaccine. 2017; 36(36):5350-5357.
PMID: 28774561
PMC: 5792371.
DOI: 10.1016/j.vaccine.2017.07.062.
The Integration of Epistasis Network and Functional Interactions in a GWAS Implicates RXR Pathway Genes in the Immune Response to Smallpox Vaccine.
McKinney B, Lareau C, Oberg A, Kennedy R, Ovsyannikova I, Poland G
PLoS One. 2016; 11(8):e0158016.
PMID: 27513748
PMC: 4981436.
DOI: 10.1371/journal.pone.0158016.
Defending against smallpox: a focus on vaccines.
Voigt E, Kennedy R, Poland G
Expert Rev Vaccines. 2016; 15(9):1197-211.
PMID: 27049653
PMC: 5003177.
DOI: 10.1080/14760584.2016.1175305.
Lessons learned in the analysis of high-dimensional data in vaccinomics.
Oberg A, McKinney B, Schaid D, Pankratz V, Kennedy R, Poland G
Vaccine. 2015; 33(40):5262-70.
PMID: 25957070
PMC: 4581898.
DOI: 10.1016/j.vaccine.2015.04.088.
Adversomics: a new paradigm for vaccine safety and design.
Whitaker J, Ovsyannikova I, Poland G
Expert Rev Vaccines. 2015; 14(7):935-47.
PMID: 25937189
PMC: 4630804.
DOI: 10.1586/14760584.2015.1038249.
TLR Agonists as Modulators of the Innate Immune Response and Their Potential as Agents Against Infectious Disease.
Mifsud E, Tan A, Jackson D
Front Immunol. 2014; 5:79.
PMID: 24624130
PMC: 3939722.
DOI: 10.3389/fimmu.2014.00079.
Vaccinomics, adversomics, and the immune response network theory: individualized vaccinology in the 21st century.
Poland G, Kennedy R, McKinney B, Ovsyannikova I, Lambert N, Jacobson R
Semin Immunol. 2013; 25(2):89-103.
PMID: 23755893
PMC: 3752773.
DOI: 10.1016/j.smim.2013.04.007.
Next generation deep sequencing and vaccine design: today and tomorrow.
Luciani F, Bull R, Lloyd A
Trends Biotechnol. 2012; 30(9):443-52.
PMID: 22721705
PMC: 7127335.
DOI: 10.1016/j.tibtech.2012.05.005.
Vaccinomics and personalized vaccinology: is science leading us toward a new path of directed vaccine development and discovery?.
Poland G, Kennedy R, Ovsyannikova I
PLoS Pathog. 2012; 7(12):e1002344.
PMID: 22241978
PMC: 3248557.
DOI: 10.1371/journal.ppat.1002344.
The top five "game changers" in vaccinology: toward rational and directed vaccine development.
Kennedy R, Poland G
OMICS. 2011; 15(9):533-7.
PMID: 21815811
PMC: 3166183.
DOI: 10.1089/omi.2011.0012.
Vaccinomics and a new paradigm for the development of preventive vaccines against viral infections.
Poland G, Ovsyannikova I, Kennedy R, Haralambieva I, Jacobson R
OMICS. 2011; 15(9):625-36.
PMID: 21732819
PMC: 3166201.
DOI: 10.1089/omi.2011.0032.
Vaccinomics: current findings, challenges and novel approaches for vaccine development.
Ovsyannikova I, Poland G
AAPS J. 2011; 13(3):438-44.
PMID: 21671143
PMC: 3160164.
DOI: 10.1208/s12248-011-9281-x.
Systems biology approaches to new vaccine development.
Oberg A, Kennedy R, Li P, Ovsyannikova I, Poland G
Curr Opin Immunol. 2011; 23(3):436-43.
PMID: 21570272
PMC: 3129601.
DOI: 10.1016/j.coi.2011.04.005.
Vaccinomics and bioinformatics: accelerants for the next golden age of vaccinology.
Poland G, Oberg A
Vaccine. 2010; 28(20):3509-10.
PMID: 20394850
PMC: 2860731.
DOI: 10.1016/j.vaccine.2010.03.031.
